Subclinical hypothyroidism in HIV-infected subjects

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 5, 2006, Pages 1086-1089

  Bongiovanni, Marco ^a   Adorni, Fulvio ^b   Casana, Maddalena ^a   Tordato, Federica ^a   Tincati, Camilla ^a   Cicconi, Paola ^a   Bini, Teresa ^a   d'Arminio Monforte, Antonella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

Author keywords

HAART; HIV; Thyroid

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHYROIDISM; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; VIROLOGY;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV; HIV INFECTIONS; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED;

EID: 34547637329     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl360     Document Type: Article

References (13)

1. Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Eng J Med 1998; 338: 853-60.
2. Mocroft A, Vella S, Benfield TL et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352: 1725-30.
3. Carr A, Samaras K, Thorisdottir A et al. Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia and diabetes mellitus: A cohort study. Lancet 1999; 353: 2093-9.
4. Bongiovanni M, Fausto A, Cicconi P et al. Osteoporosis in HIV-infected subjects: A combined effect of highly active antiretroviral therapy and HIV itself? J Acquir Immune Defic Syndr 2005; 40 503-4.
5. Raffi F, Brisseau JM, Planchon B et al. Endocrine function in 98 HIV-infected patients: A prospective study. AIDS 1991; 5: 729-33.
6. Dobs AS, Dempsey MA, Ladenson PW et al. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988; 84 611-16.
7. Helfand M. Screening for subclinical thyroid disfunction in nonpregnant adults: A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2004; 140: 128-41.
8. Grappin M, Piroth L, Verges B et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS 2000; 14: 1070-2.
9. Beltran S, Lescure FX, Desailloud R et al. Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: A need for screening. Clin Infect Dis 2003; 37: 579-83.
10. Quirino T, Bongiovanni M, Ricci E et al. Hypothyroidism in HIV-infected patients who have or have not received HAART. Clin Infect Dis 2004; 38: 596-7.
11. Merenich JA, McDermott MT, Asp AA et al. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab 1990; 70: 566-71.
12. Beltran S, Lescure FX, El Esper I et al. Subclinical hypothyroidism in HIV-infected patients is nota n autoimmune disease. Horm Res 2006; 66: 21-6.
13. Madeddu G, Spanu A, Chessa F et al. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): A longitudinal study. Clin Endocrinol 2006; 64: 375-83.